Advertisement
U.S. markets closed

NeuroOne Medical Technologies Corporation (NMTC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
0.9406-0.0593 (-5.93%)
At close: 04:00PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
3,922
1,952
171.169
178.146
0
Cost of Revenue
2,790
1,496
241.963
275.895
0
Gross Profit
1,132
456.517
-70.794
-97.749
0
Operating Expense
13,367
12,412
9,960
10,120
4,902
Operating Income
-12,235
-11,955
-10,031
-10,218
-4,902
Net Non Operating Interest Income Expense
-
-
0
-3.053
-7,525
Other Income Expense
132.582
95.759
31.152
273.096
-1,213
Pretax Income
-12,103
-11,859
-10,000
-9,948
-13,640
Tax Provision
0
0
0
-
-
Net Income Common Stockholders
-12,103
-11,859
-10,000
-9,948
-13,640
Diluted NI Available to Com Stockholders
-12,103
-11,859
-10,000
-9,948
-13,640
Basic EPS
0.00
-0.65
-0.63
-0.93
-2.52
Diluted EPS
0.00
-0.65
-0.63
-0.93
-2.52
Basic Average Shares
18,121
18,121
15,999
10,697
5,415
Diluted Average Shares
18,121
18,121
15,999
10,697
5,415
Total Operating Income as Reported
-12,235
-11,955
-10,031
-10,218
-4,902
Total Expenses
16,158
13,908
10,202
10,396
4,902
Net Income from Continuing & Discontinued Operation
-12,103
-11,859
-10,000
-9,948
-13,640
Normalized Income
-12,103
-11,859
-10,000
-9,950
-12,427
Interest Expense
-
-
0
3.053
7,525
Net Interest Income
-
-
0
-3.053
-7,525
EBIT
-12,235
-11,955
-10,031
-9,945
-6,116
EBITDA
-11,990
-11,756
-9,912
-9,864
-6,068
Reconciled Cost of Revenue
2,790
1,496
241.963
275.895
0
Reconciled Depreciation
245.173
199.266
118.62
80.748
47.609
Net Income from Continuing Operation Net Minority Interest
-12,103
-11,859
-10,000
-9,948
-13,640
Total Unusual Items Excluding Goodwill
-
-
-
1.974
-1,213
Total Unusual Items
-
-
-
1.974
-1,213
Normalized EBITDA
-11,990
-11,756
-9,912
-9,866
-4,855
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0